Overview of the cardiovascular effects of tadalafil

European Heart Journal, Supplement

Volumn 4, Issue H, 2002, Pages

  Emmick, Jeffrey T ^a   Stuewe, S R ^a   Mitchell, M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Cardiovascular adverse effects; Erectile dysfunction; Haemodynamics; Nitrates; Tadalafil

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITRATE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTERIOSCLEROSIS; ARTERY MALFORMATION; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; DRUG POTENTIATION; DRUG SAFETY; ERECTILE DYSFUNCTION; FLUSHING; HEART ARRHYTHMIA; HEART BUNDLE BRANCH BLOCK; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE EXTRASYSTOLE; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; LONG QT SYNDROME; MALE; MORTALITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; QT INTERVAL; REVIEW; RISK FACTOR; STABLE ANGINA PECTORIS; STANDING; SYNCOPE; TACHYCARDIA; THROMBOSIS; TREATMENT CONTRAINDICATION; VERTIGO;

EID: 0036893306     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90050-7     Document Type: Review

References (13)

1. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802-13.
2. Kaiser FE, Viosca SP, Morley JE, Mooradian AD, Davis SS, Korenman SG. Impotence and aging: Clinical and hormonal factors. J Am Geriatr Soc 1988; 36: 511-9.
3. Wagner G, Mulhall J. Pathophysiology and diagnosis of male erectile dysfunction. BJU Int 2001; 88(suppl 3): 3-10.
4. Kirby M, Jackson G, Betteridge J, Friedli K. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001; 55: 614-8.
5. Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123-6.
6. Jackson G, Benjamin N, Jackson N, Allen MJ. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol 1999; 83: 13-20C.
7. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: Results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999; 83: 21-8C.
8. Webb DJ, Muirhead GJ, Wulff M, Sutton JA, Levi R, Dinsmore WW. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000; 36: 25-31.
9. Vardi Y, Klein L, Nassar S, Sprecher E, Gruenwald I. Effects of sildenafil citrate (Viagra) on blood pressure in normotensive and hypertensive men. Urology 2002; 59: 747-52.
10. Kloner RA, Brown M, Prisant LM, Collins M. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens 2001; 14: 70-3.
11. Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 2000; 342: 1622-26.
12. Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999; 83: 29C-34C.
13. Sadovsky R, Miller T, Moskowitz M, Hackett G. Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract 2001; 55: 115-128.